Read all about it! The latest news from the medical technology experts
Ingeneus' unique offering: it becomes the Legal Manufacturer for clients
IOPvet gets the 'thumbs up' around the world
Ingeneus launches IOPvet device
Further patents issued in key regions for the eyePressure device
Revolutionising high eyePressure detection around Australia - and even in the Antarctic
Patents issued in key regions for the eyeTelehealth Platform
Patent issued for Ingeneus' eyeConnect device in China
Patents issued in the US and China for eyeTelehealth products
World first eyeConnect unveiled at Frankston Hospital
Ingeneus products - Good Design Awards winners
Ingeneus products in Good Design Awards finals
Ingeneus appoints new GM Manufacturing
Ingeneus launches eyePressure device
Ingeneus develops new remote assessment tool
Medical device treats Ocular Pathologies during Vitreoretinal Surgery
V-Patch Medical Systems: reaching the hearts of the travelling public
Double Success for Ingeneus in Government Program
Ingeneus advocates change to the Therapeutic Goods Administration (TGA)
Ingeneus Exhibits at AusMedtech 2011 Conference
Dynamic enhancement of Ingeneus QMS for medical devices and biomedical applications
Exciting opportunities at BiOS 2011 for Ingeneus
Ingeneus engages with emerging markets
New branding & website under Design Vic Business Immersion program
Ingeneus completes software training with its clients
Ingeneus passes TGA Surveillance Audit
Ingeneus signs licensing agreement for low cost diabetic retinopathy system
News
Medical device treats Ocular Pathologies during Vitreoretinal Surgery
10th February 2012
Retinal detachment, the separation of the retina from the underlying retinal pigment epithelium, is often a medical emergency. With approximately 3% suffering retinal detachment by the age of 85, speedy referrals and early repair can effectively treat this condition with little or no residual vision loss.
Ingeneus has developed a laser system for the treatment of retinal detachments and tears. This system is capable of intravitreal endophotocoagulation of vascular and structural abnormalities of the retina and choroid. This product has been designed as a standalone device or to be seamlessly integrated with existing vitreo-retinal surgical platforms.
Commercialisation Australia Proof of Concept funding was used in the design and development of this medical technology. This latest addition to Ingeneus’ portfolio of laser products, further showcases our experience in the ophthalmic field.
